Table 4.

Overall survival and time to progression in the 3 risk groups based on cytogenetics and circulating myeloma cells

Risk group
n
OS, mo
TTP, mo
Low   134   55   21.8  
Intermediate   81   48   15.4  
High
 		 31
 		 21.5
 		 6.5
 
Risk group
n
OS, mo
TTP, mo
Low   134   55   21.8  
Intermediate   81   48   15.4  
High
 		 31
 		 21.5
 		 6.5
 
View Large
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal